NT PHARMA (01011) has announced the completion of its acquisition of a 58.11% equity interest in Zhejiang Kangyuan Medical Equipment. The transaction, valued at approximately RMB 116 million, was finalized on March 25, 2026. The company issued and allotted 275 million new shares at an issue price of HK$0.45 per share to eight sellers as payment for the consideration. All prerequisite conditions outlined in the sale and purchase agreement and supplemental agreement, as detailed in the "Preconditions" section of the circular, have been satisfied.

The entire issued share capital of the three target companies involved in the transaction—Junbinxiongdi Limited, Yue Hua Limited, and Zhong He Qun Lian Limited—has been fully transferred and registered under the company's name. Consequently, the target companies have become indirect wholly-owned subsidiaries of NT PHARMA. Following the completion of the acquisition, the company now indirectly holds a 58.11% stake in Zhejiang Kangyuan Medical Equipment Co., Ltd. through its wholly-owned subsidiary. The financial results of Zhejiang Kangyuan Medical Equipment will be consolidated into the Group's accounts.